From: About.com ENT
A recent study reported by newswise and published in the February
2009 edition of Laryngoscope studied individuals suffering from a
condition called hereditary hemorrhagic telangiectasia (HHT). The
most prominent symptom of this condition is chronic, severe,
nosebleeds. The study used two treatment methods, KTP laser
cauterization and the nasal administration of the cancer drug
bevacizumab (Avastin). Eighty percent of patients had improved
symptoms when using both the laser treatment and the drug Avastin
compared with only 56 percent of patients who had the laser therapy
alone. Avastin is used to inhibit abnormal growth of blood vessels
in cancer patients. Stay Up To Date: Subscribe to my free
newsletter and follow me on Twitter or Facebook. Have Questions?
Find out answers to your specifi...
Respond to this topic on your own blog
Click and press Ctrl+C to copy and paste this discussion on your blog or site
Related Articles
Could Taking Gabapentin (Neurontin) Before Your Nasal Surgery Make All the Difference?
A study reported in the European Archives of Oto-Rhino-Laryngology
has reported a study that shows that taking the drug gabapentin
(Neurontin) prior to nasal surgery can reduce the amount of
medication needed during surgery, the amount of pain medication
after surgery, and overall comfort of the patient. The drug is
normally used to control neuropathic pain, often in people with
chronic pain. The study involved sixty patients who were given
gabapentin one hour before surgery as compared to another group who
were given placebo. Pain and sedation during surgery was monitored
by the anesthesiologist while the patient's pain and sedation
scores after surgery were also compared. The group having received
gabapentin consistently showed better pain control. Stay Up To
Date: Subscribe to my free n...
The First Study of H1N1 in Pediatric Patients is Released
Findings in the first study of pediatric patients with H1N1 (novel
influenza or swine flu) has been released in the journal Pediatric
Critical Care Medicine. According to an article in Newswise the
study was conducted at Johns Hopkins Children's Center between June
and August of 2009. Three important findings in this study include:
H1N1 illness tends to behave erratically in pediatric patients,
increasing the need for medical professionals to be ever vigilant
and ready to change the course of care for a given patient at any
moment, the biggest underlying illness in children who were
hospitalized for H1N1 was asthma, and, the majority of patients in
the study who were hospitalized for H1N1 originally tested negative
for H1N1 via rapid response screening tests indicating that the
current sc...
Could H1N1 Deaths Be Related To Autoimmunity?
A study reported in Newswise on the 15th of December says that
individuals who develop serious pneumonia from H1N1 infection may
have an autoimmune disorder. According to the study the
overproduction of the immune system component Interlukin 17 may be
responsible for serious illness and even death. Elevated levels of
Interlukin 17 were found in patients hospitalized with H1N1. This
substance can cause an excess number of white blood cells to
respond to lung injury caused by the swine flu virus and cause
increased inflammation in the lungs. This can lead to respiratory
failure and death. "In rare cases, the virus causes lung infections
requiring patients to be treated in hospital. By targeting or
blocking TH17 [interlukin 17] in the future, we could potentially
reduce the amount of inflamm...
Gene Responsible For Eosinophilic Esophagitis Found
A study appearing in Nature Genetics reveals the gene responsible
for eosiniophilic esophagitis. Eosinophilic esophagitis is a
condition in which, it is believed, food allergies cause a large
number of eosinophils, (a white blood cell), to accumulate at the
esophagus causing inflammation and pain and sometimes resulting in
scar tissue. Eosinophilic esophagitis is currently treated with
corticosteroids to suppress immunity but now that the gene
responsible for this condition has been discovered new treatments
may be on the horizon. "Eosinophilic esophagitis is a highly
allergic disease, and one that is rapidly expanding. This is the
first genome-wide association study done on this disease, and now
that we have elucidated a gene pathway, the hope is that physicians
can eventually intervene ...
New Drug Available for Insomnia
The Food and Drug Administration (FDA) has approved a new
pharmaceutical drug for the treatment of insomnia. The new drug,
doxepin (Silenor), has been found to be helpful to start and
maintain sleep in individuals having difficulties with this, a
characteristic of both acute and chronic insomnia. The medication
has also been used at higher doses to treat depression. Follow me
on Twitter or Facebook to receive notice of all the latest updates
to this site.New Drug Available for Insomnia originally appeared on
About.com Sleep Disorders on Monday, March 22nd, 2010 at
13:50:13.Permalink | Comment | Email this